Charles E Foulds

10PUBLICATIONS
64CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Microelectromechanical systems (MEMS)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2026
ESR1 fusions in breast cancer: functions, mechanisms and therapeutic opportunities.

|Aug 27, 2025
NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitors.

Ze-Yi Zheng, Anran Chen, Eric J Jaehnig

|Sep 25, 2024
Death-associated protein kinase 3 modulates migration and invasion of triple-negative breast cancer cells.

Junkai Wang, Anh M Tran-Huynh, Beom-Jun Kim

|May 23, 2024
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.

Anran Chen, Beom-Jun Kim, Aparna Mitra

|Mar 02, 2024
A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis.

Sangappa B Chadchan, Pooja Popli, Zian Liao

|Apr 18, 2023
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer.

Xuxu Gou, Beom-Jun Kim, Meenakshi Anurag

Pageof 2

Frequent Collaborators

5 joint publications

Matthew J Ellis

4 joint publications

Xuxu Gou

3 joint publications

Meenakshi Anurag

3 joint publications

Craig T Vollert